A comparative study on the efficacy of topical 2 percent CRISABOROLE Cream vs 0.1 percent BETAMETHASONE VALEREATE Ointment in the treatment of Plaque Psoriasis-A Non Blinded Randomised Control Study. - NI

GURUPRAKASH A V0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.Patient clinically diagnosed as Psoriasis vulgaris with less than 10 percent Body Surface Area involvement.
•2.Age above 12 years
•3. Patient willing for consent , study and follow up.
•4. Patient willing to take clinical photos.
•5. Patient not on any other treatment with topical and systemic drugs for Psoriasis for at least past 1 month.

•1.Patients below 12 years.
•2.Patients with Psoriasis involving more than 10 percent Body Surface Area.
•3.Patients with Severe Psoriasis Vulgaris and Erythrodermic Psoriasis, Pustular Psoriasis, Guttate Psoriasis, Nail Psoriasis, Psoriatic Arthritis.
•4.Patients who are on treatment with topical or systemic drugs specific to Psoriasis within past 1 month.
•5.Patients with active infection at the study site.
•6.Patient not willing for regular follow-up or to take clinical pictures.
•7.Lactating or Pregnant women.

发起方

GURUPRAKASH A V